ABSTRACT
Background: Small airway dysfunction (SAD) and airway inflammation are vital in asthma exacerbations. Type 2 inflammation (T2), mediated by cytokines from T helper 2 cell (Th2) such as interleukin (IL)-4, IL-5, and IL-13, is a potential mechanism underlying SAD. Research on small airway function in asthma is limited. We aimed to explore the correlation between small airway function and respiratory symptoms and comorbidity in T2 and non-T2 asthma. Methods: Derived from the National Health and Nutrition Examination Survey (NHANES), our study encompassed 2,420 asthma patients aged 6 - 79 years, including pulmonary function (PF) data such as forced expiratory flow between 25% and 75% of forced vital capacity (FEF25-75), forced expiratory volume in 1 second (FEV1), forced expiratory volume in 3 seconds (FEV3), forced expiratory volume in 6 seconds (FEV6), and forced vital capacity (FVC). To evaluate the small airway function, we calculated z-scores for FEF25-75, FEF25-75/FVC, FEV1/FEV6, and FEV3/FEV6. Logistic regression determined the adjusted odds ratios (aORs) for symptoms and comorbidity. Results: FEF25-75, FEV1/FEV6, and FEV3/FEV6 correlated with asthmatic symptoms. FEF25-75 had the strongest association with wheezing or whistling attacks. An increase of 1 standard deviations (SD) in FEF25-75 reduced recurrent wheezing (aOR: 0.70; 95% confidence intervals (95% CIs): 0.65 - 0.76) and severe attacks (aOR: 0.67; 95% CI: 0.62 - 0.94). These indices were also linked to dry cough and hay fever, particularly FEV3/FEV6 reducing hay fever risk (aOR: 0.70; 95% CI: 0.55 - 0.91) in non-T2 asthma. FEF25-75/FVC related to persistent (aOR: 0.78; 95% CI: 0.72 - 0.84) and severe attacks (aOR: 1.14; 95% CI: 1.08 - 1.22) in non-T2 groups. Lower indices combined with T2 exposure raised severe attack risk. Conclusions: In this nationwide study, small airway function correlated with symptom onset, especially in T2 asthma. Small airway injury differed between T2 and non-T2 asthma. Prospective research is needed to establish reference values.
ABSTRACT
Aging and aging-related diseases have emerged as increasingly severe health and social problems. Therefore, it is imperative to discover novel and effective therapeutics to delay the aging process and to manage aging-related diseases. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), one of the classes of antihyperglycemic drugs, have been recommended to manage type 2 diabetes mellitus (T2DM). Moreover, GLP-1 RAs have been shown to protect against oxidative stress, cellular senescence and chronic inflammation, which are widely accepted as the major risk factors of aging. However, their significance in aging or aging-related diseases has not been elucidated. Herein, we explain the underlying mechanisms and protective roles of GLP-1 RAs in aging from a molecular, cellular and phenotypic perspective. We provide novel insights into the broad prospect of GLP-1 RAs in preventing and treating aging-related diseases. Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases. This review forms a basis for further studies on the relationship between aging-related diseases and GLP-1 RAs.
ABSTRACT
An organophosphorous hybrid (BM@Al-PPi) with unique core-shell structure was prepared through hybridization reaction between boehmite (BM) as the inorganic substrate and phenylphosphinic acid (PPiA) as the organic modifier. Fourier transform infrared spectra (FTIR), solid state (31)P and (27)Al magic angle spinning nuclear magnetic resonance, X-ray diffraction, and element analysis were used to investigate the chemical structure of the hybrids, where the microrod-like core was confirmed as Al-PPi aggregates generated from the reaction between BM and PPiA, and those irregular nanoparticles in the shell belonged to residual BM. Compared with the traditional dissolution-precipitation process, a novel analogous suspension reaction mode was proposed to explain the hybridization process and the resulting product. Scanning electronic microscopy further proved the core-shell structure of the hybrids. BM exhibited much higher initial decomposition temperature than that of Al-PPi; therefore, the hybrid showed better thermal stability than Al-PPi, and it met the processing temperature of semi-aromatic polyamide (HTN, for instance) as an additive-type flame retardant. Limiting oxygen index and cone calorimetric analysis suggested the excellent flame-retardant performance and smoke suppressing activity by adding the resulting hybrid into HTN.
ABSTRACT
A novel multifunctional organic-inorganic hybrid was designed and prepared based on ammonium polyphosphate (APP) by cation exchange with diethylenetriamine (DETA), abbreviated as DETA-APP. Then DETA-APP was used as flame-retardant curing agent for epoxy resin (EP). Curing behavior, including the curing kinetic parameters, was investigated by differential scanning calorimetry (DSC) and X-ray photoelectron spectroscopy (XPS). The flame retardance and burning behavior of DETA-APP cured EP were also evaluated. The limiting oxygen index (LOI) value of DETA-APP/EP was enhanced to 30.5% with only 15 wt % of DETA-APP incorporated; and the UL-94 V-0 rating could be easily passed through with only 10 wt % of the hybrid. Compared with DETA/EP, the peak-heat release rate (PHRR), total heat release (THR), total smoke production (TSP), and peak-smoke production release (SPR) of DETA-APP/EP (15 wt % addition), obtained from cone calorimetry, were dropped by 68.3, 79.3, 79.0, and 30.0%, respectively, suggesting excellent flame-retardant and smoke suppression efficiency. The flame-retardant mechanism of DETA-APP/EP has been investigated comprehensively. The results of all the aforementioned studies distinctly confirmed that DETA-APP was an effective flame-retardant curing agent for EP.
